Common use of Biogen Release Clause in Contracts

Biogen Release. Biogen shall perform release testing in accordance with the Drug Substance Specifications of all DS Batches to ensure compliance with the Drug Substance Specifications and cGMPs. With respect to each DS Batch produced by Biogen under a Binding Purchase Order (or under Binding Forecast with respect to Drug Substance produced by Biogen under Section 5.2) and subject to Sections 5.2, 9.1(c) and 9.1(f), Biogen will release such Drug Substance to Bioverativ at the delivery date upon Biogen forwarding to Bioverativ by electronic transmission (as specified in the quality agreement) the DS Certificate of Analysis and the DS Certificate of Conformance (the “DS Release”). If Bioverativ submits to Biogen a written request for a copy of the related Batch Documentation, Biogen shall furnish a copy of such Batch Documentation to Bioverativ within five (5) Business Days.